492 related articles for article (PubMed ID: 22652345)
41. Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study.
Øie M; Sundet K; Rund BR
Schizophr Bull; 2010 May; 36(3):557-65. PubMed ID: 18801881
[TBL] [Abstract][Full Text] [Related]
42. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
[TBL] [Abstract][Full Text] [Related]
43. Does originating from a genetic isolate affect the level of cognitive impairments in schizophrenia families?
Torniainen M; Wedenoja J; Varilo T; Partonen T; Suokas J; Häkkinen L; Lönnqvist J; Suvisaari J; Tuulio-Henriksson A
Psychiatry Res; 2013 Jul; 208(2):111-7. PubMed ID: 23083916
[TBL] [Abstract][Full Text] [Related]
44. Prediction of patient contacts by cognition in schizophrenia.
Ernst Nielsen R; Haugaard C; Olrik Wallenstein Jensen S; Munk-Jørgensen P; Østergaard Christensen T
Aust N Z J Psychiatry; 2013 Jul; 47(7):637-45. PubMed ID: 23574875
[TBL] [Abstract][Full Text] [Related]
45. Both low birthweight and high birthweight are associated with cognitive impairment in persons with schizophrenia and their first-degree relatives.
Torniainen M; Wegelius A; Tuulio-Henriksson A; Lönnqvist J; Suvisaari J
Psychol Med; 2013 Nov; 43(11):2361-7. PubMed ID: 23360614
[TBL] [Abstract][Full Text] [Related]
46. Juvenile myoclonic epilepsy: the impact of clinical variables and psychiatric disorders on executive profile assessed with a comprehensive neuropsychological battery.
Moschetta SP; Valente KD
Epilepsy Behav; 2012 Dec; 25(4):682-6. PubMed ID: 23151472
[TBL] [Abstract][Full Text] [Related]
47. Neurocognitive function in long-term treated schizophrenia: a five-year follow-up study.
Ekerholm M; Firus Waltersson S; Fagerberg T; Söderman E; Terenius L; Agartz I; Jönsson EG; Nyman H
Psychiatry Res; 2012 Dec; 200(2-3):144-52. PubMed ID: 22657952
[TBL] [Abstract][Full Text] [Related]
48. Executive functioning in schizophrenia: Unique and shared variance with measures of fluid intelligence.
Martin AK; Mowry B; Reutens D; Robinson GA
Brain Cogn; 2015 Oct; 99():57-67. PubMed ID: 26263380
[TBL] [Abstract][Full Text] [Related]
49. Neurocognitive performance, psychopathology and social functioning in individuals at high risk for schizophrenia or psychotic bipolar disorder.
Gkintoni E; Pallis EG; Bitsios P; Giakoumaki SG
J Affect Disord; 2017 Jan; 208():512-520. PubMed ID: 27810272
[TBL] [Abstract][Full Text] [Related]
50. Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia.
Huang M; Huang Y; Yu L; Hu J; Chen J; Jin P; Xu W; Wei N; Hu S; Qi H; Xu Y
BMC Psychiatry; 2016 Oct; 16(1):344. PubMed ID: 27716115
[TBL] [Abstract][Full Text] [Related]
51. Working memory in siblings of schizophrenia patients.
Barrantes-Vidal N; Aguilera M; Campanera S; Fatjó-Vilas M; Guitart M; Miret S; Valero S; Fañanás L
Schizophr Res; 2007 Sep; 95(1-3):70-5. PubMed ID: 17628433
[TBL] [Abstract][Full Text] [Related]
52. Cognitive impairment in schizophrenia across age groups: a case-control study.
Mosiołek A; Gierus J; Koweszko T; Szulc A
BMC Psychiatry; 2016 Feb; 16():37. PubMed ID: 26908293
[TBL] [Abstract][Full Text] [Related]
53. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.
Eastvold AD; Heaton RK; Cadenhead KS
Schizophr Res; 2007 Jul; 93(1-3):266-77. PubMed ID: 17467955
[TBL] [Abstract][Full Text] [Related]
54. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
[TBL] [Abstract][Full Text] [Related]
55. Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery.
Tan EJ; Rossell SL
Schizophr Res; 2014 Jan; 152(1):242-5. PubMed ID: 24291545
[TBL] [Abstract][Full Text] [Related]
56. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
[TBL] [Abstract][Full Text] [Related]
57. Neurocognitive insight and executive functioning in schizophrenia.
Prouteau A; Atzeni T; Tastet H; Bergua V; Destaillats JM; Verdoux H
Cogn Neuropsychiatry; 2015; 20(1):64-71. PubMed ID: 25359274
[TBL] [Abstract][Full Text] [Related]
58. Selective, sustained, and shift in attention in patients with diagnoses of schizophrenia.
Hagh-Shenas H; Toobai S; Makaremi A
Percept Mot Skills; 2002 Dec; 95(3 Pt 2):1087-95. PubMed ID: 12578247
[TBL] [Abstract][Full Text] [Related]
59. Neurocognitive correlates of positive and negative syndromes in schizophrenia.
Voruganti LN; Heslegrave RJ; Awad AG
Can J Psychiatry; 1997 Dec; 42(10):1066-71. PubMed ID: 9469239
[TBL] [Abstract][Full Text] [Related]
60. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
